• Login
    View Item 
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of TUScholarShareCommunitiesDateAuthorsTitlesSubjectsGenresThis CollectionDateAuthorsTitlesSubjectsGenres

    My Account

    LoginRegister

    Help

    AboutPeoplePoliciesHelp for DepositorsData DepositFAQs

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    REGULATION OF THE HUMAN NEUROTROPIC POLYOMAVIRUS, JCV, IN THE CENTRAL NERVOUS SYSTEM

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Sariyer_temple_0225E_10572.pdf
    Size:
    2.031Mb
    Format:
    PDF
    Download
    Genre
    Thesis/Dissertation
    Date
    2011
    Author
    Sariyer, Ilker Kudret
    Advisor
    Khalili, Kamel, 1951-
    Committee member
    Gordon, Jennifer
    Rappaport, Jay
    Langford, Dianne
    Block, Timothy M.
    Department
    Biomedical Neuroscience
    Subject
    Neurosciences
    Virology
    Permanent link to this record
    http://hdl.handle.net/20.500.12613/2312
    
    Metadata
    Show full item record
    DOI
    http://dx.doi.org/10.34944/dspace/2294
    Abstract
    The human neurotropic virus, JC virus (JCV), is the etiologic agent of the fatal demyelinating disease of the central nervous system, progressive multifocal leukoencephalopathy (PML) that is seen primarily in immunodeficient individuals. Productive infection of JCV occurs only in glial cells and this restriction is to a great extent due to the activation of the viral promoter that has cell type-specific characteristics. The cell types that support the JCV infection cycle in culture are limited to primary human fetal glial cells and several transformed cell lines of glial origin. We developed a new hybrid cell system permissive for JC virus infection in order to gain insight into the mechanisms responsible for cell type specificity of JCV. The new cell system was created through the use of polyethylene glycol (PEG)-mediated cell fusion of primary human fetal astrocytes (PHFA) with an HPRT-deficient glioblastoma cell line, U-87MG. The new hybrid system was then used to analyze the ability of JCV replication and gene expression by infection studies. Results demonstrated that the new hybrid lines efficiently support JCV propagation during the early passages but lost that property in later passages. Earlier studies led to the assumption that glial-specific activation of the JCV promoter is mediated through the involvement of positive and negative transcription factors that control reactivation of the JCV genome under normal physiological conditions and suppress its activation in non-glial cells. Here we demonstrate that the alternative splicing factor, SF2/ASF, has the capacity to exert a negative effect on transcription of the JCV promoter in glial cells through direct association with a specific DNA sequence within the viral enhancer/promoter region. Our results show that down-regulation of SF2/ASF in fetal and adult glial cells increases the level of JCV gene expression and replication indicating that negative regulation of the JCV promoter by SF2/ASF may control reactivation of JCV replication in brain. JCV induces a broad range of neural-origin tumors in experimental animals has been repeatedly detected in several human cancer most notably neural-crest origin tumors, including medulloblastomas and glioblastomas. The oncogenic activity of JCV is attributed to the viral early gene products, large T and small t antigen, as evidenced by the results from in vitro cell culture and in vivo transgenic animal studies. We demonstrate that SF2/ASF suppresses the expression of large T antigen and small t antigen in JCV-transformed tumor cell lines. Expression of SF2/ASF in such tumor cells ultimately hinders the transforming capacity of the viral tumor antigens. Moreover, downregulation of SF2/ASF in viral-transformed tumor cell lines induces the growth and proliferation rate of the tumor cells. Altogether, we have created a new hybrid cell system which may serve as a good model system to study the biology of JCV aimed at identifying cellular determinants of the virus replication and gene expression as well as developing novel therapeutic intervention strategies against JCV-induced disease, PML. We have also demonstrated a novel role of the cellular alternative splicing factor, SF2/ASF, in the regulation of JCV gene expression and transformation. These observations provide a new avenue of research to understand pathogenesis of JCV-induced diseases through interplay between JCV regulatory proteins and host factors, such as SF2/ASF.
    ADA compliance
    For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
    Collections
    Theses and Dissertations

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Temple University Libraries | 1900 N. 13th Street | Philadelphia, PA 19122
    (215) 204-8212 | scholarshare@temple.edu
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.